Matthias Stelljes

47PUBLICATIONS
234CO-AUTHORS
Major global burdens of diseaseHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Oct 05, 2026
Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.

|Sep 11, 2026
Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

|Jul 08, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

|Jul 02, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

|Jun 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

Pageof 8

Frequent Collaborators

12 joint publications

Wolfgang Bethge

12 joint publications

Nicolaus Kröger

11 joint publications

Mohamad Mohty

10 joint publications

Jakob R Passweg